Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERCC5 | P28715 | 11/20 | 0.47 |
| ▸ | FEN1 | P39748 | 11/20 | 0.47 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.46 |
| ▸ | HNF4A | P41235 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 5/20 | 0.43 |
| ▸ | MPO | P05164 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6950482 | 0.82 | ERCC5 (0.62) | ERCC5FEN1HAO1HNF4APTPN1 | |
| SCHEMBL6947888 | 0.81 | ERCC5 (0.42) | ERCC5FEN1HAO1HNF4APTPN1 | |
| SCHEMBL6950947 | 0.79 | ERCC5 (0.62) | ERCC5FEN1HAO1HNF4APTPN1 | |
| SCHEMBL6950058 | 0.78 | ERCC5 (0.39) | ERCC5FEN1HAO1PTPN1LMNA | |
| SCHEMBL6948223 | 0.78 | NPC1 (0.47) | ERCC5FEN1HAO1HNF4APTPN1 | |
| SCHEMBL6949765 | 0.78 | ERCC5 (0.47) | ERCC5FEN1HAO1HNF4APTPN1 | |
| SCHEMBL6946238 | 0.77 | PTPN1 (0.53) | ERCC5FEN1HAO1PTPN1LMNA | |
| SCHEMBL6947620 | 0.77 | LTA4H (0.50) | LMNA | |
| SCHEMBL6946203 | 0.76 | LMNA (0.46) | ERCC5FEN1HAO1HNF4APTPN1 | |
| SCHEMBL6950803 | 0.76 | ERCC5 (0.44) | ERCC5FEN1HAO1HNF4APTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1082121-A4 | HIV INTEGRASE INHIBITORS | MERCK & CO INC (US) | 2003-02-05 | — | — | EP | claimed |
| US-6380249-B1 | HIV integrase inhibitors | MERCK & CO., INC. | 2002-04-30 | — | — | US | claimed |
| EP-1082121-A1 | HIV INTEGRASE INHIBITORS | Merck & Co., Inc. (US) | 2001-03-14 | — | — | EP | claimed |
| WO-1999062520-A1 | HIV INTEGRASE INHIBITORS | MERCK & CO., INC. (US) | 1999-12-09 | — | — | WO | claimed |
| EP-1082121-A4 | HIV INTEGRASE INHIBITORS | MERCK & CO INC (US) | 2003-02-05 | — | — | EP | disclosed |
| US-6380249-B1 | HIV integrase inhibitors | MERCK & CO., INC. | 2002-04-30 | — | — | US | disclosed |
| EP-1082121-A1 | HIV INTEGRASE INHIBITORS | Merck & Co., Inc. (US) | 2001-03-14 | — | — | EP | disclosed |
| WO-1999062520-A1 | HIV INTEGRASE INHIBITORS | MERCK & CO., INC. (US) | 1999-12-09 | — | — | WO | disclosed |